Clinical trial · Interventional
Iraqi Trial for Lung Cancer Screening
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Lung cancer is a global problem. Worldwide, 1.2 million people die of lung cancer each year. In Iraq, lung cancer is the most common malignancy after breast cancer and the leading cause of cancer-related death. Tobacco smoking plays a major role in lung cancer; it is reported in 85-90% of lung cancer patients yet environmental tobacco smoke, environmental and domestic air pollution, work-related risk factors, radon exposure, and viruses may also have an impact on lung cancer incidence rates. Early detection of the disease before patients develop symptoms considers the best way to improve patient outcomes. IT LUCAS is designed to evaluate the utility of low-dose computed tomography (LDCT) screening in early detection and management of lung cancer in high-risk people.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| low dose CT | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- screening
- description
- Participants undergo low dose CT of the chest
- interventionNames
- Diagnostic Test: low dose CT
Primary outcomes (1)
- measure
- The efficacy of LD CT in lung cancer screening
- timeFrame
- 2 years
- description
- The number of lung nodules with Lung RADS 4A, 4B and 4X, cancer predictive value and false-positive value
Secondary outcomes (1)
- measure
- noncancerous lung lesions
- timeFrame
- 2 years
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * male or female * aged between 50 and 75 * smokers or ex-smoker * tobacco exposure of more than 30 pack-years Exclusion Criteria: * History of cancer within the last 5 years other than non-melanoma skin cancer or carcinoma in situ, * heart or respiratory severe co-morbidity with contraindications to thoracoscopy
References
Publications (0)
Data not yet available